These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT). Luguya R; Fronczek FR; Smith KM; Vicente MG Appl Radiat Isot; 2004 Nov; 61(5):1117-23. PubMed ID: 15308202 [TBL] [Abstract][Full Text] [Related]
24. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. Peng Q; Moan J; Ma LW; Nesland JM Cancer Res; 1995 Jun; 55(12):2620-6. PubMed ID: 7780978 [TBL] [Abstract][Full Text] [Related]
25. Photodynamic effects of sulfonated aluminum chlorophthalocyanine in human urinary bladder carcinoma cells in vitro. Müller M; Reich E; Steiner U; Heicappell R; Miller K Eur Urol; 1997; 32(3):339-43. PubMed ID: 9358224 [TBL] [Abstract][Full Text] [Related]
26. Proposal of modified mechanisms for photodynamic therapy. Leupold D; Freyer W J Photochem Photobiol B; 1992 Feb; 12(3):311-3. PubMed ID: 1635015 [No Abstract] [Full Text] [Related]
27. A novel synthetic route to fused propenochlorin and benzochlorin photodynamic therapy probes. Li G; Mehta R; Srikrishnan T; Nurco DJ; Tabaczynski WA; Alderfer JL; Smith KM; Dougherty TJ; Pandey RK Chem Commun (Camb); 2002 Jun; (11):1172-3. PubMed ID: 12109067 [TBL] [Abstract][Full Text] [Related]
28. Photofrin as a specific radiosensitizing agent for tumors: studies in comparison to other porphyrins, in an experimental in vivo model. Schaffer M; Schaffer PM; Corti L; Gardiman M; Sotti G; Hofstetter A; Jori G; Dühmke E J Photochem Photobiol B; 2002 Apr; 66(3):157-64. PubMed ID: 11960724 [TBL] [Abstract][Full Text] [Related]
29. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity. Hilmey DG; Abe M; Nelen MI; Stilts CE; Baker GA; Baker SN; Bright FV; Davies SR; Gollnick SO; Oseroff AR; Gibson SL; Hilf R; Detty MR J Med Chem; 2002 Jan; 45(2):449-61. PubMed ID: 11784149 [TBL] [Abstract][Full Text] [Related]
30. Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta-galactoside-recognized proteins. Li G; Pandey SK; Graham A; Dobhal MP; Mehta R; Chen Y; Gryshuk A; Rittenhouse-Olson K; Oseroff A; Pandey RK J Org Chem; 2004 Jan; 69(1):158-72. PubMed ID: 14703392 [TBL] [Abstract][Full Text] [Related]
31. Clinical use of hematoporphyrin derivative in malignant tumors. Ha XW; Sun XM; Xie JG; Fan XJ; Zhang YH; Mei QC; Shen H; Xu SL; Zhang RG Chin Med J (Engl); 1983 Oct; 96(10):754-8. PubMed ID: 6233105 [No Abstract] [Full Text] [Related]
32. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Selman SH; Kreimer-Birnbaum M; Klaunig JE; Goldblatt PJ; Keck RW; Britton SL Cancer Res; 1984 May; 44(5):1924-7. PubMed ID: 6231988 [TBL] [Abstract][Full Text] [Related]
33. [Electron microscopic observation on human bladder cancer tissue after photodynamic therapy]. Zhou CN Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Jun; 10(3):176-8. PubMed ID: 2972405 [No Abstract] [Full Text] [Related]
34. Comment on "Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle-invasive bladder cancer" by Lui Shiong Lee et al. [Photodiagn Photodyn Ther 2010;7:213-20]. Waidelich R Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):221. PubMed ID: 21112543 [No Abstract] [Full Text] [Related]
35. Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo. Zhang LJ; Zhang XH; Liao PY; Sun JJ; Wang L; Yan YJ; Chen ZL J Photochem Photobiol B; 2016 Oct; 163():224-31. PubMed ID: 27591565 [TBL] [Abstract][Full Text] [Related]
37. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Hua Z; Gibson SL; Foster TH; Hilf R Cancer Res; 1995 Apr; 55(8):1723-31. PubMed ID: 7712481 [TBL] [Abstract][Full Text] [Related]
40. Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model. Baglo Y; Peng Q; Hagen L; Berg K; Høgset A; Drabløs F; Gederaas OA Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):58-66. PubMed ID: 25575731 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]